A Study of Esomeplazole (D961H) in Japanese Paediatric Patients With Reflux Esophagitis, Gastric Ulcer or Duodenal Ulcer
Conditions:   Reflux Esophagitis;   Gastric Ulcer;   Duodenal Ulcer Interventions:   Drug: D961H capsule 10mg;   Drug: D961H sachet 10mg Sponsor:   AstraZeneca Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 12, 2018 Category: Research Source Type: clinical trials

Special dr ug Use Surveillance of Takecab for " Prevention of Recurrence of Gastric/Duodenal Ulcer in Patients Receiving Non-steroidal Anti-inflammatory Drugs: Long-term Use " Prevention of Recurrence of Gastric/Duodenal Ulcer in Patients Receiving Non-steroidal Anti-inflammatory Drugs:Long-term Use
Condition:   A History of Gastric or Duodenal Ulcers Intervention:   Drug: Vonoprazan Sponsor:   Takeda Recruiting - verified July 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 9, 2017 Category: Research Source Type: clinical trials

Special Drug Use Surveillance of Takecab for " Prevention of Recurrence of Gastric/Duodenal Ulcer in Patients Receiving Low-dose Aspirin: Long-term Use "
Condition:   Gastric or Duodenal Ulcers Intervention:   Drug: Vonoprazan Sponsor:   Takeda Recruiting - verified July 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 9, 2017 Category: Research Source Type: clinical trials

Special dr ug Use Surveillance of Takecab for " Prevention of Recurrence of Gastric/Duodenal Ulcer in Patients Receiving Non-steroidal Anti-inflammatory Drugs: Long-term Use " Prevention of Recurrence of Gastric/Duodenal Ulcer in Patients Receiving Non-steroidal Anti-inflammatory Drugs:Long-term Use
Condition:   A History of Gastric or Duodenal Ulcers Intervention:   Drug: Vonoprazan Sponsor:   Takeda Recruiting - verified July 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 9, 2017 Category: Research Source Type: clinical trials

Special Drug Use Surveillance of Takecab for " Prevention of Recurrence of Gastric/Duodenal Ulcer in Patients Receiving Low-dose Aspirin: Long-term Use "
Condition:   Gastric or Duodenal Ulcers Intervention:   Drug: Vonoprazan Sponsor:   Takeda Recruiting - verified July 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 9, 2017 Category: Research Source Type: clinical trials

Drug Use Surveillance of Takecab for " Gastric Ulcer, Duodenal Ulcer, and Reflux Esophagitis "
Condition:   Gastric Ulcer, Duodenal Ulcer, and Reflux Esophagitis Intervention:   Drug: Vonoprazan Sponsor:   Takeda Recruiting - verified July 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 9, 2017 Category: Research Source Type: clinical trials

Special dr ug Use Surveillance of Takecab for " Prevention of Recurrence of Gastric/Duodenal Ulcer in Patients Receiving Non-steroidal Anti-inflammatory Drugs: Long-term Use " Prevention of Recurrence of Gastric/Duodenal Ulcer in Patients Receiving Non-steroidal Anti-inflammatory Drugs:Long-term Use
Condition:   A History of Gastric or Duodenal Ulcers Intervention:   Drug: Vonoprazan Sponsor:   Takeda Recruiting - verified July 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 9, 2017 Category: Research Source Type: clinical trials

Drug Use Surveillance of Takecab for " Gastric Ulcer, Duodenal Ulcer, and Reflux Esophagitis "
Condition:   Gastric Ulcer, Duodenal Ulcer, and Reflux Esophagitis Intervention:   Drug: Vonoprazan Sponsor:   Takeda Recruiting - verified July 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 9, 2017 Category: Research Source Type: clinical trials

Special Drug Use Surveillance of Takecab for " Prevention of Recurrence of Gastric/Duodenal Ulcer in Patients Receiving Low-dose Aspirin: Long-term Use "
Condition:   Gastric or Duodenal Ulcers Intervention:   Drug: Vonoprazan Sponsor:   Takeda Recruiting - verified July 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 9, 2017 Category: Research Source Type: clinical trials

Drug Use Surveillance of Takecab for " Gastric Ulcer, Duodenal Ulcer, and Reflux Esophagitis "
Condition:   Gastric Ulcer, Duodenal Ulcer, and Reflux Esophagitis Intervention:   Drug: Vonoprazan Sponsor:   Takeda Recruiting - verified July 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 9, 2017 Category: Research Source Type: clinical trials

Special dr ug Use Surveillance of Takecab for " Prevention of Recurrence of Gastric/Duodenal Ulcer in Patients Receiving Non-steroidal Anti-inflammatory Drugs: Long-term Use " Prevention of Recurrence of Gastric/Duodenal Ulcer in Patients Receiving Non-steroidal Anti-inflammatory Drugs:Long-term Use
Condition:   A History of Gastric or Duodenal Ulcers Intervention:   Drug: Vonoprazan Sponsor:   Takeda Recruiting - verified July 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 9, 2017 Category: Research Source Type: clinical trials

Special Drug Use Surveillance of Takecab for " Prevention of Recurrence of Gastric/Duodenal Ulcer in Patients Receiving Low-dose Aspirin: Long-term Use "
Condition:   Gastric or Duodenal Ulcers Intervention:   Drug: Vonoprazan Sponsor:   Takeda Recruiting - verified July 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 9, 2017 Category: Research Source Type: clinical trials

Drug Use Surveillance of Takecab for " Gastric Ulcer, Duodenal Ulcer, and Reflux Esophagitis "
Condition:   Gastric Ulcer, Duodenal Ulcer, and Reflux Esophagitis Intervention:   Drug: Vonoprazan Sponsor:   Takeda Recruiting - verified July 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 9, 2017 Category: Research Source Type: clinical trials

Special Drug Use Surveillance of Takecab for " Prevention of Recurrence of Gastric/Duodenal Ulcer in Patients Receiving Low-dose Aspirin: Long-term Use "
Condition:   Gastric or Duodenal Ulcers Intervention:   Drug: Vonoprazan Sponsor:   Takeda Recruiting - verified July 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 9, 2017 Category: Research Source Type: clinical trials

Special dr ug Use Surveillance of Takecab for " Prevention of Recurrence of Gastric/Duodenal Ulcer in Patients Receiving Non-steroidal Anti-inflammatory Drugs: Long-term Use " Prevention of Recurrence of Gastric/Duodenal Ulcer in Patients Receiving Non-steroidal Anti-inflammatory Drugs:Long-term Use
Condition:   A History of Gastric or Duodenal Ulcers Intervention:   Drug: Vonoprazan Sponsor:   Takeda Recruiting - verified July 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 9, 2017 Category: Research Source Type: clinical trials

Drug Use Surveillance of Takecab for " Gastric Ulcer, Duodenal Ulcer, and Reflux Esophagitis "
Condition:   Gastric Ulcer, Duodenal Ulcer, and Reflux Esophagitis Intervention:   Drug: Vonoprazan Sponsor:   Takeda Recruiting - verified July 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 9, 2017 Category: Research Source Type: clinical trials

Special dr ug Use Surveillance of Takecab for " Prevention of Recurrence of Gastric/Duodenal Ulcer in Patients Receiving Non-steroidal Anti-inflammatory Drugs: Long-term Use " Prevention of Recurrence of Gastric/Duodenal Ulcer in Patients Receiving Non-steroidal Anti-inflammatory Drugs:Long-term Use
Condition:   A History of Gastric or Duodenal Ulcers Intervention:   Drug: Vonoprazan Sponsor:   Takeda Recruiting - verified July 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 9, 2017 Category: Research Source Type: clinical trials

Special Drug Use Surveillance of Takecab for " Prevention of Recurrence of Gastric/Duodenal Ulcer in Patients Receiving Low-dose Aspirin: Long-term Use "
Condition:   Gastric or Duodenal Ulcers Intervention:   Drug: Vonoprazan Sponsor:   Takeda Recruiting - verified July 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 9, 2017 Category: Research Source Type: clinical trials

Special dr ug Use Surveillance of Takecab for " Prevention of Recurrence of Gastric/Duodenal Ulcer in Patients Receiving Non-steroidal Anti-inflammatory Drugs: Long-term Use " Prevention of Recurrence of Gastric/Duodenal Ulcer in Patients Receiving Non-steroidal Anti-inflammatory Drugs:Long-term Use
Condition:   A History of Gastric or Duodenal Ulcers Intervention:   Drug: Vonoprazan Sponsor:   Takeda Recruiting - verified July 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 9, 2017 Category: Research Source Type: clinical trials

Drug Use Surveillance of Takecab for " Gastric Ulcer, Duodenal Ulcer, and Reflux Esophagitis "
Condition:   Gastric Ulcer, Duodenal Ulcer, and Reflux Esophagitis Intervention:   Drug: Vonoprazan Sponsor:   Takeda Recruiting - verified July 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 9, 2017 Category: Research Source Type: clinical trials

Drug Use Surveillance of Takecab for " Supplement to Helicobacter Pylori Eradication "
Condition:   Gastric/Duodenal Ulcer, Gastric MALT Lymphoma, Idiopathic Thrombocytopenic Purpura, or H. Pylori Gastritis, and Other Interventions:   Drug: Vonoprazan;   Drug: Amoxicillin hydrate;   Drug: Clarithromycin;   Drug: Metronidazole Sponsor:   Takeda Completed - verified July 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 9, 2017 Category: Research Source Type: clinical trials

Special dr ug Use Surveillance of Takecab for " Prevention of Recurrence of Gastric/Duodenal Ulcer in Patients Receiving Non-steroidal Anti-inflammatory Drugs: Long-term Use " Prevention of Recurrence of Gastric/Duodenal Ulcer in Patients Receiving Non-steroidal Anti-inflammatory Drugs:Long-term Use
Condition:   A History of Gastric or Duodenal Ulcers Intervention:   Drug: Vonoprazan Sponsor:   Takeda Recruiting - verified July 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 9, 2017 Category: Research Source Type: clinical trials

Special Drug Use Surveillance of Takecab for " Prevention of Recurrence of Gastric/Duodenal Ulcer in Patients Receiving Low-dose Aspirin: Long-term Use "
Condition:   Gastric or Duodenal Ulcers Intervention:   Drug: Vonoprazan Sponsor:   Takeda Recruiting - verified July 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 9, 2017 Category: Research Source Type: clinical trials

Drug Use Surveillance of Takecab for " Gastric Ulcer, Duodenal Ulcer, and Reflux Esophagitis "
Condition:   Gastric Ulcer, Duodenal Ulcer, and Reflux Esophagitis Intervention:   Drug: Vonoprazan Sponsor:   Takeda Recruiting - verified July 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 9, 2017 Category: Research Source Type: clinical trials

Drug Use Surveillance of Takecab for " Supplement to Helicobacter Pylori Eradication "
Condition:   Gastric/Duodenal Ulcer, Gastric MALT Lymphoma, Idiopathic Thrombocytopenic Purpura, or H. Pylori Gastritis, and Other Interventions:   Drug: Vonoprazan;   Drug: Amoxicillin hydrate;   Drug: Clarithromycin;   Drug: Metronidazole Sponsor:   Takeda Completed - verified July 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 9, 2017 Category: Research Source Type: clinical trials

Special Drug Use Surveillance of Takecab for " Prevention of Recurrence of Gastric/Duodenal Ulcer in Patients Receiving Low-dose Aspirin: Long-term Use "
Condition:   Gastric or Duodenal Ulcers Intervention:   Drug: Vonoprazan Sponsor:   Takeda Recruiting - verified July 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 9, 2017 Category: Research Source Type: clinical trials

Drug Use Surveillance of Takecab for " Supplement to Helicobacter Pylori Eradication "
Condition:   Gastric/Duodenal Ulcer, Gastric MALT Lymphoma, Idiopathic Thrombocytopenic Purpura, or H. Pylori Gastritis, and Other Interventions:   Drug: Vonoprazan;   Drug: Amoxicillin hydrate;   Drug: Clarithromycin;   Drug: Metronidazole Sponsor:   Takeda Completed - verified July 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 9, 2017 Category: Research Source Type: clinical trials

Special dr ug Use Surveillance of Takecab for " Prevention of Recurrence of Gastric/Duodenal Ulcer in Patients Receiving Non-steroidal Anti-inflammatory Drugs: Long-term Use " Prevention of Recurrence of Gastric/Duodenal Ulcer in Patients Receiving Non-steroidal Anti-inflammatory Drugs:Long-term Use
Condition:   A History of Gastric or Duodenal Ulcers Intervention:   Drug: Vonoprazan Sponsor:   Takeda Recruiting - verified July 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 9, 2017 Category: Research Source Type: clinical trials

Drug Use Surveillance of Takecab for " Gastric Ulcer, Duodenal Ulcer, and Reflux Esophagitis "
Condition:   Gastric Ulcer, Duodenal Ulcer, and Reflux Esophagitis Intervention:   Drug: Vonoprazan Sponsor:   Takeda Recruiting - verified July 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 9, 2017 Category: Research Source Type: clinical trials

Special Drug Use Surveillance of Takecab for " Prevention of Recurrence of Gastric/Duodenal Ulcer in Patients Receiving Low-dose Aspirin: Long-term Use "
Condition:   Gastric or Duodenal Ulcers Intervention:   Drug: Vonoprazan Sponsor:   Takeda Recruiting - verified July 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 9, 2017 Category: Research Source Type: clinical trials

Special dr ug Use Surveillance of Takecab for " Prevention of Recurrence of Gastric/Duodenal Ulcer in Patients Receiving Non-steroidal Anti-inflammatory Drugs: Long-term Use " Prevention of Recurrence of Gastric/Duodenal Ulcer in Patients Receiving Non-steroidal Anti-inflammatory Drugs:Long-term Use
Condition:   A History of Gastric or Duodenal Ulcers Intervention:   Drug: Vonoprazan Sponsor:   Takeda Recruiting - verified July 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 9, 2017 Category: Research Source Type: clinical trials

Drug Use Surveillance of Takecab for " Gastric Ulcer, Duodenal Ulcer, and Reflux Esophagitis "
Condition:   Gastric Ulcer, Duodenal Ulcer, and Reflux Esophagitis Intervention:   Drug: Vonoprazan Sponsor:   Takeda Recruiting - verified July 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 9, 2017 Category: Research Source Type: clinical trials

Drug Use Surveillance of Takecab for " Supplement to Helicobacter Pylori Eradication "
Condition:   Gastric/Duodenal Ulcer, Gastric MALT Lymphoma, Idiopathic Thrombocytopenic Purpura, or H. Pylori Gastritis, and Other Interventions:   Drug: Vonoprazan;   Drug: Amoxicillin hydrate;   Drug: Clarithromycin;   Drug: Metronidazole Sponsor:   Takeda Completed - verified July 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 9, 2017 Category: Research Source Type: clinical trials

Drug Use Surveillance of Takecab for " Gastric Ulcer, Duodenal Ulcer, and Reflux Esophagitis "
Condition:   Gastric Ulcer, Duodenal Ulcer, and Reflux Esophagitis Intervention:   Drug: Vonoprazan Sponsor:   Takeda Recruiting - verified July 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 9, 2017 Category: Research Source Type: clinical trials

Special dr ug Use Surveillance of Takecab for " Prevention of Recurrence of Gastric/Duodenal Ulcer in Patients Receiving Non-steroidal Anti-inflammatory Drugs: Long-term Use " Prevention of Recurrence of Gastric/Duodenal Ulcer in Patients Receiving Non-steroidal Anti-inflammatory Drugs:Long-term Use
Condition:   A History of Gastric or Duodenal Ulcers Intervention:   Drug: Vonoprazan Sponsor:   Takeda Recruiting - verified July 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 9, 2017 Category: Research Source Type: clinical trials

Special Drug Use Surveillance of Takecab for " Prevention of Recurrence of Gastric/Duodenal Ulcer in Patients Receiving Low-dose Aspirin: Long-term Use "
Condition:   Gastric or Duodenal Ulcers Intervention:   Drug: Vonoprazan Sponsor:   Takeda Recruiting - verified July 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 9, 2017 Category: Research Source Type: clinical trials